Objective: Preloaded endovascular delivery systems expand the anatomic eligibility for complex aortic repair by requiring only one iliac access vessel and providing a stable platform for guiding sheaths into challenging target vessels. This article reports the lessons learned and early clinical outcomes using a modified preloaded delivery system for fenestrated endovascular aneurysm repair (FEVAR) in three aortic centers in Europe.
In aneurysms involving or adjacent to the visceral segment of the aorta, endovascular repair using a fenestrated stent graft (fenestrated endovascular aneurysm repair [FEVAR] ) represents the most reliable endovascular option, as it removes the artificial boundary of the renal and visceral arteries in the selection of the proximal sealing zone. [1] [2] [3] Two anatomic obstacles that challenge complex endovascular repair are the steep angles at which some visceral branch arteries adjoin the aorta, and the compromised access of patients with occluded or stenotic iliac arteries because of native pathology or previous intervention. A preloaded delivery system, in theory, addresses both of these issues. Housing two sheaths in the ipsilateral delivery system both creates a stable platform for guiding sheaths to cannulate steep branches, and provides access to branches from the ipsilateral side, obviating the need for contralateral access. A design including a preloaded wire through each renal fenestration was created and first assessed in 2010. 4 A technical assessment of this device reported that using a preloaded delivery system is feasible and may reduce the time for target vessel catheterization, the operative time, the contrast volume and the radiation exposure compared with a standard FEVAR. 5 However, as with many endovascular systems, the initial design was cumbersome, and recent changes have been made to improve ease of implantation to allow for more widespread adoption. This article reports the lessons learned and early clinical outcomes using this modified preloaded system for FEVAR in three European centers.
METHODS
The first 30 consecutive patients meeting anatomic criteria for a complex aneurysm endovascular repair and repaired with a custom made modified preloaded custom stent graft from three participating centers were prospectively included in the study. The decision to use this delivery system was made at the discretion of the implanting surgeon and was considered standard of care as the modifications of the device did not include any novel or untested components. The United Kingdom authors sought guidance from Health Research Authority (HRA) and were advised that this study did not fall under the remit of the National Health Service (NHS) Research Ethics Committee, thus, it is registered with the Royal Free NHS Foundation Trust as an audit in line with clinical guidelines. In France and Sweden, a written informed consent was always obtained.
Demographics, medical history, procedure-related data, and postoperative course were recorded for all patients for planned analysis. The authors at three centers follow similar follow-up protocols for complex endovascular repair, and postoperative computed tomography angiogram was obtained within 30 days after the procedure as part of standard of care. Complications were self-reported by each center and defined using the Society for Vascular Surgery's reporting standards for endovascular aortic aneurysm repair. 6, 7 Device design. This new design is a modification of previous preloaded fenestrated stent graft delivery system (Zenith pivot branch device; Cook Medical, Inc, Bloomington, Ind) with the primary goal of improves the ease of implantation (S. Haulon, B. Roeder, inventors).
The implant consists of a fenestrated stent graft composed of polyester fabric sewn to self-expanding nitinol stents with braided polyester and monofilament polypropylene suture that incorporate at least two fenestrations for the renal arteries. The introduction system features a hydrophilic Flexor introducer sheath (Cook Medical, Inc), with a hemostatic valve, a flexible short nose tip, and an inner nitinol cannula. Single-or double-diameter reducing ties are linked to the trigger wires to partially deploy the stent graft and allow the operator minor adjustment of the height and rotation.
The primary change to the implant is the removal of the proximal stainless steel uncovered stent from the previous design, and the proximal covered stent has the same design as in the TX2 system (Zenith TX2 thoracic stent graft; Cook Medical, Inc). It contains barbs directed caudally to augment the necessary attachment and seal of the stent graft to the vessel wall and is maintained by the trigger wire in a trifold configuration during the catheterization of the target vessels.
The primary change to the delivery system is the manner in which the renal fenestrations are preloaded. In the previous design, a singular wire facilitated access to the renal fenestrations. 5 With the modified design, there is a separate preloaded wire and catheter is used to create a path from the control handle, through the center of the stent graft and through each renal fenestration (Fig 1) . These catheters and wires terminate proximal to the stent graft and sit in grooves in the dilator tip.
Device implantation. The key changes to the device implantation sequence are detailed in Table I . Surgeons from the three centers developed and agreed on these instructions based on early bench trials and the initial Fig 1. a, Dilator tip. b, Control handle. c, Catheter path through graft (sheath withdrawn). The preloaded wires and catheters create a path from the control handle, through the delivery system, into the distal lumen of the stent-graft, through each renal fenestration, proceed outside the proximal stent graft and sit in grooves in the dilator tip.
cases. One step that was inconsistent between centers was the wire used in advancing preloaded sheaths; the Amplatz wire (Boston Scientific, Marlborough, Mass) was replaced by a Lundequist (Cook Medical Inc, Bloomington, Ind) or a Rosen wire (Cook Medical Inc). All surgeons agreed this deviation was likely inconsequential to clinical outcome, and, thus, the variation was permitted. In all three centers, standard of care included using fusion imaging for implantation of all complex devices.
Outcomes and statistical analysis. Classification of the aneurysms was reported according to the reporting standards using the proximal and distal attachment site. 7 Patients with three fenestrations (both renal arteries and superior mesenteric artery [SMA] ) and one scallop for the celiac trunk, and a >20 mm proximal sealing zone above the SMA were included in the type IV thoracoabdominal aortic aneurysm group. Specific endovascular outcomes, including technical success, adjunctive maneuvers, endoleaks, deaths, and adverse events, were analyzed and reported in accordance with Society for Vascular Surgery reporting standards. 6, 7 Primary technical success was defined as successful introduction and deployment of the device in the absence of surgical conversion or mortality, successful stenting of all fenestrations intended in the surgeons plan, the absence of type I endoleak or obstruction of branch vessels on completion angiography, and survival through 24 hours. Fenestrations that were intended to be unstented in the surgeon's original plan (primarily the celiac artery in both scallops and some fenestrations) and remained unstented after the procedure were not included in the definition of technical failure. Assisted primary technical success captures unplanned endovascular procedure in the first 24 hours. The period of learning of the modified preloaded system was assessed by recording adherence to the agreed instruction for use but was primarily adjudicated based on the use of the preloaded sheaths for access into the intended renal arteries. Finally, we aimed to report on the effect that preloaded delivery has on the ease and duration of the procedure, and recorded the variables mean procedure time, fluoroscopy time, dose area product, and contrast volume as surrogate markers for efficiency of repair. This is a descriptive report of a variation on a technique, thus, planned statistical analyses were not complex. Data were reported as mean, standard deviation, and frequencies. All analyses were conducted using Epi Info 3.5.3 software (Centers for Disease Control and Prevention, Atlanta, Ga). Given the small sample size and short duration of follow-up, time to event analyses and associative statistics were not appropriate, and, thus, not planned.
RESULTS
From October 2015 to March 2016, the first 30 consecutive patients (80% men; 70 6 8 years) assessed and deemed eligible for endovascular repair using this device are reported. The types of repairs included fall into three categories: fenestrated conversion of type Ia endoleak (3/30; 10%), type I-II-III thoracoabdominal (8/30; 27%), or type IV thoracoabdominal or pararenal (19/30; 63%) aneurysm repair. In addition to the three patients with the previous failed endovascular aneurysm repair (EVAR), two patients had a history of open abdominal aortic aneurysm repair including one with an ilio-SMA bypass, and one with a history of thoracic EVAR. Two patients presenting with a type II thoracoabdominal aortic aneurysm underwent a thoracic EVAR as a planned staged procedure months earlier. The mean aortic diameter at time of repair was 64 6 13 mm. Additional demographic data are provided in Table II .
Operative details. The conformation of devices used in this population were similar: 29 were implanted with stent grafts conformations that included only fenestrations, including 58 modified preloaded renal fenestrations, 28 SMA, and 23 celiac trunk fenestrations. One patient received a stent graft combining three branches and one modified preloaded fenestration for one renal, Table I . Key changes to the device implantation sequence 1 . Device is tracked into position using standard fenestrated practices, taking care to properly position the stent graft prior to withdrawal of the delivery sheath and continually monitoring position and making any necessary adjustments during withdrawal of the delivery sheath.
2. Replace wires preloaded into catheters with 0.035-inch Amplatz wires advance both wires into the thoracic aorta.
3. Remove both preloaded catheters.
4. Advance 6 F, 90-cm sheaths over Amplatz wires until the tip of the sheath protrudes from the corresponding fenestration.
5. Remove sheath dilators from the 6F, 90-cm sheaths.
6. Replace catheters over each Amplatz wire and exchange for a 0.018-inch, leaving only the 0.018-inch wire and the sheath.
7. Through each 6F, 90-cm sheath, use an additional selective catheter and soft wire soft wire guide to access each target vessel.
8. Once each catheter is in the target vessel, the soft wire guide can be exchanged for a stiff wire (Rosen).
9. The 0.018-inch wire should be removed prior to tracking each sheath into its target artery.
10. With sheaths in each target vessel, including any target arteries cannulated from a contralateral approach, the remainder of the procedure is completed per standard fenestrated practices with the exception of top stent deployment. Rather than needing to remove a top cap, the proximal end is deployed by simply removing the release that removes the trifold wires. The delivery tip may be moved inferior to the fenestrations prior to placement of covered stents.
and another had a previous nephrectomy, thus, in total there were 58 preloaded fenestrations available for assessment. The primary technical success rate was 93%, and the assisted primary technical success 97%. The one technical failure was due to laparotomy at the index procedure to manage an iliac artery perforation. The one assisted primary technical failure was due to the management of a SMA dissection with distal malperfusion treated with an additional stenting on the operative day when recognized a few hours later. The repairs in these 30 patients were efficient when compared with the published literature. The mean procedure time (from skin incision to skin closure) was 277 6 153 minutes with a fluoroscopy time of 79 6 36 minutes, dose area product of 112 6 90 Gy cm 2 and contrast volume of 87 6 46 mL. Details are reported in Table III , and a comparison to published outcomes for nonpreloaded reports in both fusion and nonfusion cohorts is in Table IV . [8] [9] [10] [11] [12] [13] [14] [15] [16] Thirty-day outcomes. The 30-day mortality rate was 7% (2 of 30). Deaths and major adverse events were cerebrovascular events (n ¼ 2) including one fatal event; iliac artery perforation (n ¼ 1) requiring perprocedural open conversion leading to postoperative sepsis and death; access site major hematoma (n ¼ 1); bowel ischemia (n ¼ 1) related to the SMA dissection and malperfusion treated with additional stenting; pulmonary infection (n ¼ 1); and lower limb ischemia (n ¼ 1). On the 30-day postoperative imaging, which was completed for 28 of 30 patients, 100% of the target vessels were patent; we observed five type II endoleaks, no type I or III endoleaks, and one occlusion of an internal to external iliac artery stent. Perioperative outcomes are detailed in Table V .
Successful use of the preloaded system. The renal fenestrations were successfully catheterized and stented with a good results using ipsilateral sheaths in the preloaded system in 53 out of 58 renal arteries (91%). These five events had no negative clinical impact but represent the period of learning for device implantation. In two renal arteries the catheterization was performed from the contralateral side because of unsuccessful attempt from the preloaded system, and in three others, the preloaded wire was unintentionally sacrificed because of an error in the sequence of deployment. The distribution of these learning events according to the procedural date is illustrated in Fig 2. In addition, in three renal arteries, the branch stent required was larger and longer than the 6 Â 22 mm covered balloon expandable stent commonly available in two Centers (Advanta V12; Atrium Medical Inc, Hudson, NH; 6 Â 22 mm) that can be accommodated by the 6F preloaded sheaths. This undersizing of branch stent was responsible for a type III endoleak identified and treated intraoperatively with an additional stent implanted from ipsilateral (6 Â 22 mm) or contralateral side (7 Â 22 mm and 6 Â 38 mm) successfully.
DISCUSSION
We report initial experience with a modified preloaded delivery system for use in FEVAR of complex aneurysms in patients with compromised iliac access, or anticipated challenging renal arteries. When used in 30 patients, with 58 planned preloaded fenestrations, the successful utilization of the preloaded catheters was possible in 53 of 58 renal arteries. The remaining five renal arteries had stents placed successfully from the contralateral side without negative clinical impact. Many of the instances where contralateral access of the renal arteries was required occurred early in the experience. The 30-day imaging follow-up for 28 of 30 patients revealed 100% renal artery patency. In addition to their potential to simplify the procedure, preloaded systems provide another means of access (in addition to contralateral access) in most cases. Multiple means of accessing fenestrations may lower the rates of technical failure. Over the last 2 decades, there have been continuous improvements in endovascular devices, ancillary equipment, and techniques used for fenestrated repair to expand anatomic eligibility to a wider number of patients. Two anatomic challenges that thwart traditional fenestrated systems are the steep renal artery angulations, and stenotic or occluded iliac access. The modified preloaded delivery system, with stabilizing guiding sheaths through the ipsilateral delivery shaft, addresses both of these issues, thus, expanding the eligibility of repair to a larger number of patients. Previous reports of preloaded systems have included multiple steps that require familiarity with different delivery system components and deployment sequences. The modified preloaded delivery system incorporates more familiar design elements with a standardized technique in an effort to improve the ease of implantation without compromising durability of repair. The final goal in the evolution of fenestrated device delivery is to shorten learning curves and encourage widespread adoption. 17 The original concept of a preloaded system comes from the identification of a technically challenging step toward the FEVAR implantation, which is the establishment of stiff wire access from within the stent graft, across the fenestration and into the target vessel. 4 To overcome this issue, the preloaded wire allows a long 6F sheath to be advanced through the main body then through the fenestration, keeping it in a stable position into the fenestration until a complete access to the target vessel with a stiff wire has been obtained, through a double puncture of the sheath. The number of steps is reduced as should be the time required to catheterize the target vessels. Bisdas et al 5 have reported their experience using the previous design of the preloaded FEVAR. 5 Compared with standard FEVAR, they have shown the two systems to be similar regarding outcomes, but a significant reduction in operative time, contrast volume, mean fluoroscopy time and radiation exposure when using the preloaded system. This preloaded concept has also been included in an off-the-shelf fenestrated device that is under development and the subject of several clinical studies (Zenith p-Branch device; Cook Medical, Inc), to reduce the time-consuming step of fenestration cannulation, in addition to eliminating the requisite time required to custom made device. Kitagawa et al 18 reported a favorable early experience using this device, with a high rate of technical success and minimal problems during the short follow-up duration, as well as a simpler implantation compared with conventional fenestrated devices.
Another challenge faced in the modern delivery of FEVAR devices is the need of bilateral large caliber sheaths (20F or 22F), which can be occlusive in the iliac arteries. Bilateral iliac occlusion may be responsible for lower limb ischemia and compartment syndrome if the procedure is prolonged and also may impact spinal cord injury. 19 To address this issue, the preloaded system requires only one iliac access vessel for both the device and the renal fenestration implantation, without increasing delivery sheath size thanks to the use of LP fabric (most delivery systems are 20F or 22F). Thus, the contralateral sheath diameter is reduced or absent, depending on the number of nonpreloaded fenestrations. In addition, in more complex cases, such as the rescue of a failed short bodied, or aortouniiliac EVAR, the placement of an aortouniiliac device along with a proximal fenestrated component is the only option, making a single iliac delivery system obligatory. 20 Early iterations of preloaded delivery systems have revealed technical challenges that have led to the refined latest version assessed in this study. Several characteristics have been redesigned. First, the new version includes a shortened, smooth introducer tip instead of a self-capturing top cap to facilitate its retraction and removal. Shortening the tip was necessary to allow for flaring of the bridging stents inside the main body before the delivery system was removed, and changing to a smoothed introducer tip decreases the risk of entrapment or deformation of the newly placed branched stents caused by tortuous anatomy. In the new design, the uncovered top stent is removed, and trigger wires hold the proximal end closed in a trifold fashion similar at the Zenith TX2 thoracic stent graft (Cook Medical, Inc) to allow minimal repositioning of the stent graft once unsheathed. Second, the previous through and through preloaded wire has been replaced by two separated preloaded wires and catheter. This has maintained the stability of the preloaded sheaths, has lessened the force to remove the preloaded wire, and reduced the risk of trapping a through preloaded wire inside the stent graft.
It is interesting to note that although this delivery system included only minor changes and only used in expert aortic centers, our results clearly underline a period of learning within the initial cases, with instances of conversion to a conventional renal access through the contralateral femoral artery because of several reasons. In two renal arteries, access was unsuccessful from the preloaded system. Although access may have been also unsuccessful with the standard preloaded system, the effect of the modified system could not be ruled out. There were multiple instances where preloaded wires were lost due to an error in the sequence of deployment. Specifically, these errors involved wires used to advance the preloaded sheaths and timing of preloaded catheter removal. The preloaded wire must be exchanged and preloaded catheter removed only after complete sheath withdrawal. The deployment procedure was also been refined during this period, operators sharing their experience after each case and finalized after the first few cases. This indicates that, even in expert hands with surgeons actively involved in the design, a period of learning exists and more bench practice is likely needed for surgeons initiating this device in their own practice. Lessons should be learned about how we should be preparing for new improvement of the existing devices to overcome potential worsening results, as the margins for error are small, and the consequences of minor errors could be severe. One proposed benefit of preloaded delivery system is the improved efficiency in the operating room. In this study, we report mean procedure time, fluoroscopy time, dose area product, and contrast volume as surrogate markers for efficiency of repair. Compared with the published literature, our mean dose area product (112 6 90 Gy cm 2 ), and contrast volume (87 6 46 mL) are lower than the weighted average of other reports using fusion without preloaded system. One limitation remaining with the preloaded system is the lack of space inside the introduction system that allows room for only two 6F sheaths. The Advanta V12 (Atrium) covered stent is the most commonly used bridging stent in fenestrated stent-grafting, and requires a 7F sheath for sizes >6 mm in diameter and >22 mm in length. Even if a small stent is introduced and then molded with a larger balloon to fit the anatomy, in a 7-or 8-mm renal artery or in a fenestration remote from the artery, this carries a risk of dislodging before a secure fixation with a larger balloon and a risk of type III endoleak. 21 We reported in our series two cases of intraoperative type III endoleaks because of the use of undersized stent. These events have been successfully addressed by the implantation of an additional larger or longer stent from the contralateral side. One center has opted to use lower profile branch stents (Bentley InnoMed GmbH, Hechingen, Germany) so the appropriately sized stent is placed in the first instance. This underline the urgent need of dedicated stents available, fitting a 6F sheath and offering a wide range of diameters and lengths, and speaks to a need to assess the caliber and length of branch stent needed in renal arteries before embarking on a preloaded repair in jurisdictions where lower caliber branch stents are not available. Other limitations are the narrow working Learning curve associated with the use of the modified preloaded system. Preloaded system: the renal artery had been catheterized and stented using the preloaded system.
space between the tip of the introducer sheath and the origin of the target vessel that can incommode the flaring of the stent through the fenestration; and the need for long sheaths, catheters, and balloons that are not always easy to handle. An iteration of this delivery system that will allow the use of short catheters is required to ease those procedures. Although we attempted to accurately describe our early experience and period of learning, this study has a number of limitations. The population reported is small and is influenced by a small number of events, which have a level of significance that cannot be determined. The duration of follow-up is also quite short, therefore, the durability of the repair cannot be assessed. Furthermore, although these devices are intended for patients with compromised iliac access, this population does not reflect that characteristic, therefore, further research is needed into the ramifications of extending fenestrated repair to a patient population with occlusive disease, or iatrogenic iliac occlusion, which may carry with it a heavier burden of comorbidities. The major complications reported, including two perioperative deaths, are not related to the preloaded system, but underline the complexity of these repairs on a high-risk population of patients. Finally, we stress the interesting point that a learning curve existed, even in a group of surgeons responsible for development of a device and delivery system, suggesting that changes in practice are difficult to effect without some expectation of early error. The ongoing evolution of endovascular technology is needed to reach the right balance between ease of implantation, safety, and durability.
CONCLUSIONS
Overall, the early experience of three high volume centers using the latest refined design of preloaded fenestrated stent graft delivery system is encouraging, although does carry a period of learning that should be anticipated when incorporating this technique into practice. The preloaded technique aims to reduce the number of steps and the time required to catheterize the target vessels, as well as requiring only one iliac access vessel. Our results reflect the period of learning associated with the use of this modified preloaded system and the complexity of such patients. Further studies are warranted before this new technology becomes widespread. 
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